CYTK
Cytokinetics, Incorporated (CYTK) Sec Form 8K
Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 8K
Cytokinetics, Incorporated (CYTK) Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Conference
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Announcement
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Announcement
Cytokinetics, Incorporated (CYTK) Cytokinetics Announces Recipients of Its Eighth Annual Communications Grant Program
Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release
Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ: CYTK) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Diane Weiser — Senior Vice President,…
Cytokinetics, Incorporated (CYTK) Q2 2022
Cytokinetics, Incorporated (NASDAQ: CYTK) Q2 2022 Earnings Conference
Cytokinetics, Incorporated (CYTK) Q1 2022 earnings call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q1 2022 Earnings Conference
Cytokinetics, Incorporated (CYTK) Q4 2021 Earnings Conference
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2021 Earnings Conference